| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
Amitivir manufacturers
- Amitivir
-
- $80.00
-
2026-07-27
- CAS:111393-84-1
- Purity: 97.35%
- Supply Ability: 10g
|
| | Amitivir Basic information |
| Product Name: | Amitivir | | Synonyms: | LY-217896;Amitivir;Cyanamide, N-1,3,4-thiadiazol-2-yl-;Inhibitor,antiviral,thomyxovirus,inhibit,paramyxovirus CD-1,mice,Influenza Virus,Amitivir;Amitivir, 10 mM in DMSO;[(1,3,4-Thiadiazol-2-yl)amino]formonitrile | | CAS: | 111393-84-1 | | MF: | C3H2N4S | | MW: | 126.14 | | EINECS: | | | Product Categories: | | | Mol File: | 111393-84-1.mol |  |
| | Amitivir Chemical Properties |
| Boiling point | 236.3±23.0 °C(Predicted) | | density | 1.613±0.06 g/cm3(Predicted) | | pka | -0.94±0.10(Predicted) |
| | Amitivir Usage And Synthesis |
| Uses | Amitivir (LY 217896), a thiadiazole derivative, possesses broad antiviral activity against orthomyxo- and paramyxoviruses. Amitivir is effective against influenza A and B viruses[1][2]. | | Definition | ChEBI: Amitivir is a secondary amine. | | in vivo | Amitivir (LY 217896) (9 mg/m2 of body surface area per day) administered in the diet, in the drinking water, by oral gavage, by intraperitoneal injection, or by aerosolization was well tolerated and protected CD-1 mice infected with a lethal dose of influenza A or B virus[2]. | | References | [1] Hayden FG, et al. Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans. Antimicrob Agents Chemother. 1994;38(5):1178-1181. DOI:10.1128/AAC.38.5.1178
[2] Colacino JM, et al. Evaluation of the anti-influenza virus activities of 1,3,4-thiadiazol-2-ylcyanamide (LY217896) and its sodium salt. Antimicrob Agents Chemother. 1990;34(11):2156-2163. DOI:10.1128/AAC.34.11.2156 |
| | Amitivir Preparation Products And Raw materials |
|